TSVT: 2seventy bio, Inc. Stock

by  •  • Comments Off on TSVT: 2seventy bio, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 202.23
Enterprise Value ($M) 142.24
Book Value ($M) 228.10
Book Value / Share 4.42
Price / Book 0.89
NCAV ($M) -57.27
NCAV / Share -1.11
Price / NCAV -3.53

Profitability (mra)
Return on Invested Capital (ROIC) -0.20
Return on Assets (ROA) -0.15
Return on Equity (ROE) -0.31

Liquidity (mrq)
Quick Ratio 4.95
Current Ratio 4.95

Balance Sheet (mrq) ($M)
Current Assets 218.48
Assets 503.85
Liabilities 275.74
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income 0.00
Net Income 0.00

Cash Flow Statement (mra) ($M)
Cash From Operations 0.00
Cash from Investing 0.00
Cash from Financing 0.00

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
11-06 13G/A Morgan Stanley 5.50 -40.76
02-14 13G/A Citadel Advisors Llc 0.30
02-14 13G/A Baker Bros. Advisors Lp 4.99
02-13 13G/A Vanguard Group Inc 7.87 65.78
02-08 13G Goldman Sachs Group Inc 8.80
02-01 13G/A Millennium Management Llc 4.70
01-26 13G/A BlackRock, Inc. 7.70 30.10
01-23 13G/A State Street Corp 1.93 -8.56
2023-11-09 13G/A Wellington Management Group Llp 1.59

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-11-12 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-08-08 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-05-09 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-03-07 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K
2023-12-01 10-Q/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q/A AMENDMENT NO. 1
2023-12-01 10-Q/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q/A AMENDMENT NO. 1
2023-12-01 10-K/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K/A AMENDMENT NO. 1
2023-12-01 10-Q/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q/A AMENDMENT NO. 1

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-11-15 88,678 393,599 22.53
2024-11-14 66,888 253,984 26.34
2024-11-13 38,339 182,718 20.98
2024-11-12 57,153 304,914 18.74
2024-11-11 31,387 186,779 16.80

(click for more detail)

Similar Companies
TNYA – Tenaya Therapeutics, Inc. TRML – Tourmaline Bio, Inc.
TSHA – Taysha Gene Therapies, Inc. TWST – Twist Bioscience Corporation
TXMD – TherapeuticsMD, Inc.


Financial data and stock pages provided by
Fintel.io